Evidence map›Paper›PMID 42290676›Full record

ArticleNeurology. Genetics2026

Blood Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Candidate Biomarkers in

Xavier Ayrignac, Cecilia Marelli, Sylvain Lehmann, Camille Huiban, Hemmo A F Yska, Pierre Labauge, Isabelle Le Ber, Fanny Mochel

Abstract read
In one paragraph

Article in Neurology. Genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xavier AyrignacUniv Montpellier, Department of Neurology, Reference Center for Adult Leukodystrophies, CHU Montpellier, INSERM, France.ORCID https://orcid.org/0000-0003-3834-2981
Cecilia MarelliEPHE, INSERM, Reference Center for Neurogenetic Diseases, CHU Montpellier, Montpellier University, France.ORCID https://orcid.org/0000-0002-9543-6311
Sylvain LehmannLBPC-PPC, CHU Montpellier, INSERM, Univ Montpellier, France.ORCID https://orcid.org/0000-0001-6117-562X
Camille HuibanINSERM 1127, Sorbonne Universités, Université Pierre et Marie Curie-Paris Université, Paris 06, Unité Mixte de Recherche (UMR) S1127, Centre National de la Recherche Scientifique (CNRS), UMR 7225, Paris Brain Institute.ORCID https://orcid.org/0009-0006-8478-4405
Hemmo A F YskaINSERM 1127, Sorbonne Universités, Université Pierre et Marie Curie-Paris Université, Paris 06, Unité Mixte de Recherche (UMR) S1127, Centre National de la Recherche Scientifique (CNRS), UMR 7225, Paris Brain Institute.ORCID https://orcid.org/0009-0002-7973-2724
Pierre LabaugeUniv Montpellier, Department of Neurology, Reference Center for Adult Leukodystrophies, CHU Montpellier, INSERM, France.ORCID https://orcid.org/0000-0001-7759-8555
Isabelle Le BerINSERM 1127, Sorbonne Universités, Université Pierre et Marie Curie-Paris Université, Paris 06, Unité Mixte de Recherche (UMR) S1127, Centre National de la Recherche Scientifique (CNRS), UMR 7225, Paris Brain Institute.ORCID https://orcid.org/0000-0002-2508-5181
Fanny MochelINSERM 1127, Sorbonne Universités, Université Pierre et Marie Curie-Paris Université, Paris 06, Unité Mixte de Recherche (UMR) S1127, Centre National de la Recherche Scientifique (CNRS), UMR 7225, Paris Brain Institute.ORCID https://orcid.org/0000-0003-3970-3486

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Colony-stimulating factor receptor 1-related disorder ( Methods: We analyzed 22 patients with Results: NfL and GFAP were elevated in Discussion: Our results show that blood NfL and GFAP are promising biomarkers of disease progression in patients with

Identifiers

PMID42290676
PMCPMC13262667

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.